Canine hyperlipidaemia.
Xenoulis PG, Steiner JM.
J Small Anim Pract. 2015 Oct;56(10):595-605. doi: 10.1111/jsap.12396.
Lipid metabolism and classification of hyperlipaemias.
Real JT, Ascaso JF.
Clin Investig Arterioscler. 2021 May;33 Suppl 1:3-9. doi: 10.1016/j.arteri.2020.12.008.
Endocrine diseases as causes of secondary hyperlipidemia.
Bułdak Ł, Marek B, Kajdaniuk D, Urbanek A, Janyga S, Bołdys A, Basiak M, Maligłówka M, Okopień B.
Endokrynol Pol. 2019;70(6):511-519. doi: 10.5603/EP.a2019.0041.
[Hyperlipidemia].
Márk L.
Orv Hetil. 2006 Jul 9;147(27):1284-5.
Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis.
Tummala R, Gupta M, Devanabanda AR, Bandyopadhyay D, Aronow WS, Ray KK, Mamas M, Ghosh RK.
Ann Med. 2022 Dec;54(1):1287-1296. doi: 10.1080/07853890.2022.2059559.
[Hyperlipidemia and osteoarticular manifestations].
Goupille P, Soutif D, Fouquet B, Valat JP.
Rev Med Interne. 1991 Mar-Apr;12(2):146-52. doi: 10.1016/s0248-8663(05)81380-3.
Statin-fibrate combination: therapy for hyperlipidemia: a review.
Wierzbicki AS, Mikhailidis DP, Wray R, Schacter M, Cramb R, Simpson WG, Byrne CB.
Curr Med Res Opin. 2003;19(3):155-68. doi: 10.1185/030079903125001668.
[Hyperlipidemia management in Slovakia: observational study].
Fábryová U, Nemcová A.
Vnitr Lek. 2020 Winter;65(12):761-769.
Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms.
Panahi Y, Ahmadi Y, Teymouri M, Johnston TP, Sahebkar A.
J Cell Physiol. 2018 Jan;233(1):141-152. doi: 10.1002/jcp.25756. Epub 2017 Jun 6.
Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARalpha.
Chen Z, Sun X, Li X, Liu N.
Biochem Pharmacol. 2023 Feb;208:115379. doi: 10.1016/j.bcp.2022.115379. Epub 2022 Dec 13.
